These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4208506)

  • 1. Comparative in vitro activity of three aminoglycosidic antibiotics: BB-K8, kanamycin, and gentamicin.
    Yu PK; Washington JA
    Antimicrob Agents Chemother; 1973 Aug; 4(2):133-9. PubMed ID: 4208506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the in vitro activities of BB-K8 and three other aminoglycosides against 215 strains of Pseudomonas and Enterobacteriaceae with variable sensitivity to kanamycin and gentamicin.
    Yourassowsky E; Schoutens E; Vanderlinden MP
    Chemotherapy; 1975; 21(1):45-51. PubMed ID: 807457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro studies of BB-K8, a new aminoglycoside antibiotic.
    Bodey GP; Stewart D
    Antimicrob Agents Chemother; 1973 Aug; 4(2):186-92. PubMed ID: 4790938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of five aminocyclitol antibiotics in vitro against Enterobacteriaceae and Pseudomonas.
    Karney W; Holmes KK; Turck M
    Antimicrob Agents Chemother; 1973 Mar; 3(3):338-42. PubMed ID: 4275226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial effectiveness ofkanamycin, aminosidin, BB-K8, sisomicin, gentamicin and tobramycin combined with carbenicillin or cephalothin against gram-negative rods.
    Klastersky J; Nyamubeya B; Vandenborre L
    J Med Microbiol; 1974 Nov; 7(4):465-72. PubMed ID: 4217836
    [No Abstract]   [Full Text] [Related]  

  • 6. Newer aminoglycosides--amikacin and tobramycin: an in-vitro comparison with kanamycin and gentamicin.
    Reynolds AV; Hamilton-Miller JM; Brumfitt W
    Br Med J; 1974 Sep; 3(5934):778-80. PubMed ID: 4213265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of BB-K8 (amikacin) against clinical isolates resistant to one or more aminoglycoside antibiotics.
    Price KE; Pursiano TA; DeFuria MD
    Antimicrob Agents Chemother; 1974 Feb; 5(2):143-52. PubMed ID: 4209522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial synergism of piperacillin and gentamicin against pseudomonas aeruginosa, Staphylococcus aureus and Streptococcus faecalis.
    Bach VT; Webb DW; Thadepalli H
    Chemotherapy; 1980; 26(1):21-7. PubMed ID: 6766372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of the antibacterial activity of amikacin (BB-K8) with other aminoglycosides against pathogens recently isolated from clinical materials (author's transl) ].
    Kosakai N; Oguri T
    Jpn J Antibiot; 1975 Aug; 28(4):530-7. PubMed ID: 240047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro evaluation of a new aminoglycoside derivative of kanamycin, a comparison with tobramycin and gentamycin.
    Ries K; Levison ME; Kaye D
    Antimicrob Agents Chemother; 1973 Apr; 3(4):532-3. PubMed ID: 4790607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative synergistic activity of netilmicin-piperacillin versus gentamicin-piperacillin.
    Machka K; Baierl W; Braveny I
    Eur J Clin Microbiol; 1982 Aug; 1(4):238-42. PubMed ID: 6217066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro studies with Sch 21420 and Sch 22591: activity in comparison with six other aminoglycosides and synergy with penicillin against enterococci.
    Sanders CC; Sanders WE; Goering RV
    Antimicrob Agents Chemother; 1978 Aug; 14(2):178-84. PubMed ID: 697346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibacterial activity of a new semisynthetic aminoglycoside antibiotic amikacin (BB-K8) (author's transl)].
    Mitsuhashi S; Kawabe H; Iyobe S; Tanaka T; Inoue M
    Jpn J Antibiot; 1974 Apr; 27(2):189-92. PubMed ID: 4211300
    [No Abstract]   [Full Text] [Related]  

  • 14. High-content aminoglycoside disks for determining aminoglycoside-penicillin synergy against Enterococcus faecalis.
    Sahm DF; Torres C
    J Clin Microbiol; 1988 Feb; 26(2):257-60. PubMed ID: 3125218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of Amikacin (BB-K8) and gentamicin activity in vitro against Proteus rettgeri.
    Pérez-Rodríguez F; Bermúdez RH; de Brau CJ
    Bol Asoc Med P R; 1977 Jul; 69(7):222-6. PubMed ID: 268183
    [No Abstract]   [Full Text] [Related]  

  • 16. UK31214, a new aminoglycoside and derivative of kanamycin B.
    Wise R; Andrews JM; Bedford KA
    Antimicrob Agents Chemother; 1980 Mar; 17(3):298-301. PubMed ID: 6775590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early synergistic interaction between semisynthetic penicillins and aminoglycosidic aminocyclitols against Enterobacteriaceae.
    Glew RH; Pavuk RA
    Antimicrob Agents Chemother; 1983 Jun; 23(6):902-6. PubMed ID: 6225391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties of an R plasmid in Pseudomonas aeruginosa producing amikacin (BB-K8), butirosin, kanamycin, tobramycin, and sisomicin resistance.
    Jacoby GA
    Antimicrob Agents Chemother; 1974 Dec; 6(6):807-10. PubMed ID: 4217586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative activity of tobramycin and gentamicin against Pseudomonas, Proteus and Providencia species.
    Ducan IB; Penner JL
    Can Med Assoc J; 1975 Jul; 113(1):29-31. PubMed ID: 807310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative activity of netilmicin, gentamicin, amikacin, and tobramycin against Pseudomonas aeruginosa and Enterobacteriaceae.
    Briedis DJ; Robson HG
    Antimicrob Agents Chemother; 1976 Oct; 10(4):592-7. PubMed ID: 825032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.